What if the director of a treatment organization is approached by researchers interested in testing an intervention for gambling disorders? That director is then confronted with a decision that involves weighing the risks of a clinical trial against the potential benefits for the clients who participate in the trial and the larger society. How can treatment providers ensure that such research would be conducted ethically? In this dispatch from the Midwest Conference on Problem Gambling & Substance Abuse, I report on Dr. Catherine Striley’s workshop on “Research & Practice Ethics: What You Need to Know.”
